Research

January 15, 2025

Alzheimer’s study details abnormal gene expression tied to blood vessel growth

The study sets out how gene expression that drives the formation of new blood vessels exhibits different patterns, cell by cell, in the brains of people with Alzheimer’s disease.

By Paul Govern
January 8, 2025

Study suggests a new way to treat incurable lung disease

IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the airways.

By Bill Snyder
January 6, 2025

VUMC study shows identifying changes in vision may be sufficient to diagnose mild TBI

In both military and civilian populations, when TBI patients are asked to fill out a symptom inventory, about 80% of them will self-report difficulty reading or other vision problems.

By Nancy Humphrey
January 3, 2025

AI tested for alerting clinicians of suicide risk at three VUMC clinics

At neurology clinics the system was used to flag 8% of arriving patients as having relatively high risk for suicide attempt in the next 30 days.

By Paul Govern
December 19, 2024

Proteomic signature a key to early detection of fatty liver disease: study

Currently, methods to detect early, obesity-related accumulation of fat in the liver other than a liver biopsy — the surgical removal of liver tissue for microscopic examination — are limited. But there is hope.

By Bill Snyder
December 18, 2024

VUMC part of multisite team investigating genetic markers of anorexia nervosa

With funding from the newly established Sarah Kyle Anorexia Nervosa Research Foundation, the researchers hope to identify biomarkers that will point to novel targets for prevention and treatment.

By Leigh MacMillan
December 17, 2024

Study shows drop in use of antiviral medications in young children with influenza

Flu illness accounts for up to 10% of all pediatric hospitalizations during the winter season in the United States.
By Jessica Pasley
December 17, 2024

Immune-suppressing drug does not improve COVID-19 recovery: study

Previous studies suggested that fostamatinib may suppress inflammatory responses triggered by COVID-19 and mitigate ongoing lung injury, decreasing mortality and oxygen requirements.
By Bill Snyder
December 16, 2024

There goes the sun

Too much screen time might leave little darling deficient in vitamin D.
By Paul Govern
December 16, 2024

VUMC awarded $26.4 million for patient-centered research

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.
By Bill Snyder
December 11, 2024

Study uses AI to cast light on harmful drug-drug interactions

Using AI, a team identified a gap in post-market drug safety: not all published reports of dangerous drug interactions are taken up by recognized purveyors of drug safety information.
By Paul Govern
December 11, 2024

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.
By Bill Snyder and Herschel Pollard
December 10, 2024

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
By Tom Wilemon
1 … 11 12 13 14 15 … 136